HomeLearnNews

News

October 20, 2017

Jackie Manthorne Recognised with Jack Shapiro Lifetime Achievement Award

Ottawa, ON - Jackie Manthorne, President and CEO of the Canadian Cancer Survivor Network (CCSN), has spent over twenty years giving a voice to cancer patients, survivors and caregivers. This...
Read More
October 19, 2017

Watch: Webinar on biosimilars

Biologic cancer treatments have become incredibly important in oncology, but they can be expensive. Biosimilars are molecules manufactured to replicate the effects of biologics. They give patients and providers a...
Read More
October 12, 2017

Watch our webinar titled “Cancer Associated Blood Clots”

This webinar introduces you to the effects of blood clots on cancer patients. This webinar also provides you with the following information: How and why blood clots effect cancer patients more...
Read More
October 12, 2017

Avelumab Survey

The purpose of this survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about the use of Avelumab for the treatment of patients with Merkel cell...
Read More
October 2, 2017

Have you experienced a blood clot during cancer treatment?

If you or a loved one has experienced a blood clot after you were diagnosed with cancer or during chemotherapy, you live in Ontario and would like to help CCSN...
Read More
October 2, 2017

Cancer Patients Celebrate New Program for Take-Home Cancer Medications in Nova Scotia

Halifax, Nova Scotia, September 27, 2017 – The CanCertainty Coalition, the united voice of 35 Canadian cancer organizations, applauds the McNeil Government's decision to address the funding gap for take-home...
Read More
September 26, 2017

Watch our webinar titled “How Changes to the Patented Medicine Prices Review Board Could Affect Patients’ Access to Drugs”

This webinar introduces you to the Patented Medicine Prices Review Board (PMPRB), how they regulate drug pricing in Canada and the proposed changes that will affect cancer patients. This webinar...
Read More
September 22, 2017

New First Line Treatment Now Available for Canadians with Metastatic Non-Small Cell Lung Cancer

KIRKLAND, QC, Sept. 20, 2017 /CNW Telbec/ - Merck (NYSE: MRK), known as MSD outside Canada and the United States, announced today that KEYTRUDA® (pembrolizumab) as monotherapy is now indicated for the treatment of metastatic non-small cell...
Read More
September 21, 2017

First-in-class BRCA-positive Ovarian Cancer Medicine Lynparza® (olaparib) Receives Positive pan-Canadian Oncology Drug Review (pCODR) Recommendation for Provincial Reimbursement

This marks an important first step towards providing Canadian women with access to this treatment MISSISSAUGA, ON, Sept. 21, 2017 /CNW/ - AstraZeneca Canada is pleased to announce that the pan-Canadian Oncology Drug...
Read More
September 14, 2017

Cancer-Associated Thrombosis: A Critical Gap in Cancer Care

"Cancer-associated thrombosis (CAT) is one of the most common yet preventable causes of death among cancer patients. With over 20,000 Canadians being diagnosed with cancer each year, knowing about causes,...
Read More
1 … 34 35 36 37 38 … 66